Company Exploring Alternative Value Creation Opportunities
Convertible note for $500,000.00 USD, Short-term Debt Reduced and Balance Sheet Strengthened to Prepare the Company for Long Term Funding.
04.06.2024 - Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ( Lobe or the Company ), a biopharmaceutical company focused on developing transformative medicines to treat diseases with unmet medical needs and rare diseases announced the evaluation of strategic . Seite 1
The North Carolina Biotechnology Center awarded 71 grants and loans totaling $2,757,090 to universities, bioscience companies and non-profit organizations in the third quarter of its fiscal year.The awards, made in January, February and March, will support life science research, technology commercialization and entrepreneurship throughout North Carolina. The funding will also help universities and companies attract follow-on funding from other sources.
From fintech to film, Wilmington executives talk industry outlooks wilmingtonbiz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wilmingtonbiz.com Daily Mail and Mail on Sunday newspapers.
The WilmingtonBiz 100: The Innovators wilmingtonbiz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wilmingtonbiz.com Daily Mail and Mail on Sunday newspapers.